First Irish case of blood clot after AstraZeneca vaccine 

The first Irish case of a rare blood clot arising after vaccination with the AstraZeneca jab is being investigated by the Irish regulator. 

State watchdog, the Health Products Regulatory Authority (HPRA), said it had received “a case of interest associated with the AstraZeneca vaccine, which describes CVST, an unusual clot in the brain.”

The 40-year-old Dublin woman is being treated at the Mater Hospital for cerebral venous sinus thrombosis (CVST) according to the Irish Times. She is expected to be discharged later in the week.

This is the first report of a blood clot arising in Ireland after the AstraZeneca vaccination according to the regulator.

The woman’s sister told the Irish Times that though she was a healthy woman she suffered severe headaches after receiving the AstraZeneca jab, and was sick in bed for two days after receiving her first dose.

When she went to her doctor, she was sent immediately to the Mater Hospital.

It’s reported that the woman was informed she would be out of work for three months, not be able to drive for six weeks – and that she would need to live with a relative for weeks or months for observation.

Yesterday, the European Medical Agency (EMA) said blood clots can be a “very rare side effect” of the AstraZeneca vaccine against Covid-19.

The medical regulator’s statement comes after weeks of uncertainty in countries across the world, with some nations suspending the vaccine’s use temporarily and others re-commencing its distribution.

The EMA said it would not support banning the injection because the danger posed by Covid-19 is greater than that of any potential side-effects from the inoculation.

Share mdi-share-variant mdi-twitter mdi-facebook mdi-whatsapp mdi-telegram mdi-linkedin mdi-email mdi-printer mdi-chevron-left Prev Next mdi-chevron-right Related
Comments are open

The biggest problem Ireland faces right now is:

View Results

Loading ... Loading ...